Novel antigen modulation treatments for cancer and autoimmune 蜜桃TV
Novel antigen modulation treatments to guide the immune system
Many 蜜桃TV are caused, or resist treatment, because T cells can't recognize or target cells correctly.
Our approach modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system.鈥
This marks a fundamental shift in how we treat people living with cancers and autoimmune disorders.
We seek to solve immune dysfunction.
Many 蜜桃TV are caused, or resist treatment, because T cells can't recognize or target cells correctly.
Our approach modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system.鈥
This marks a fundamental shift in how we treat people living with cancers, autoimmune disorders, and infectious 蜜桃TV.鈥
We seek to solve immune dysfunction.
Progressing through the clinic鈥
We uncover novel biology to 蜜桃TV treatments for disease areas with significant unmet need.
Our clinical assets in oncology (GRWD5769) and autoimmunity (GRWD0715)聽are delivering strong results in a Phase 1/2 trials.
We have active discovery and 蜜桃TVment programs across oncology and autoimmunity.
Our team and collaborators are experts in the field of antigen modulation. 聽
A new therapeutic branch
鈥媁e are the first to explore the untapped potential of changing the first step of the T cell signaling cascade (Signal 1) and its fundamental importance in T cell activation.鈥
Changing the treatment paradigm
We're on a mission to deliver a new therapeutic class of treatments to help people living with cancers and autoimmune disorders.
We're looking for talented individuals to join our award-winning team. Do you have what it takes?
